Biozona Weekly: ASU biomarker research; New Barrow center; Algae products

January 17, 2014

By hammersmith

Death dust: The valley-fever menace
1/20/14 Edition | The New Yorker | Dana Goodyear

Valley fever increased dramatically between 1998 and 2011 and is the second-most-reported disease in Arizona, yet funding remains far below other diseases that affect far less people but impact a greater geographic area.

ASU cancer biomarker research getting national attention
1/15/14 | KJZZ | Dennis Lambert

The Biodesign Institute at Arizona State University is getting national attention for groundbreaking research into the early detection of colon, breast, lung and other forms of cancer.

Barrow opens treatment center for Lou Gehrig’s disease
1/15/14 | KJZZ | Dennis Lambert

Barrow Neurological Institute at St. Joseph’s Hospital is opening a new center to focus on research and treatment of Lou Gehrig’s disease and other neuromuscular diseases, such as muscular dystrophy and multiple sclerosis.

Biosciences equate to big business in Arizona

1/14/14 | Arizona Public Media | Georgia Davis

Three of southern Arizona’s bioscience leaders discussed the growth of the biosciences in Arizona and Tucson over the past decade and talked of the need to continue to support the industry and the new updated Bioscience Roadmap that will be released in April.

Group aims for biomarker standards
1/14/14 | The Scientist | Kerry Grens

The National Biomarker Development Alliance (NBDA) at Arizona State University seeks to get more biomarkers on the market and help to create rules–such as best practices and standard operating procedures–for biomarker development that will be shared with patient groups, researchers, and physicians.

Ex-UA president Shelton leaves Fiesta Bowl, joins Tucson science foundation
1/14/14 | Arizona Daily Star | Associated Press

Former University of Arizona president Robert Shelton has resigned as executive director of the Fiesta Bowl to become the president of the Tucson-based Research Corporation for Science Advancement, a foundation that funds scientific research. 

Gov. Brewer pushes for more TGen funding
1/14/14 | Phoenix Business Journal | Angela Gonzales

In her “State of the State” address, Gov. Jan Brewer called for a dedicated funding source for the Translational Genomics Research Institute to serve as a catalyst in developing the state’s bioscience industry.

2014 job growth-slow but improving

1/11/14 | Flagstaff Business News | Bonnie Stevens

While Flagstaff’s job growth is projected to be slow this year, Flagstaff officials say the community has much to offer biotech and manufacturing companies looking to relocate or expand and hire locally.

The pitch: Biotech solution zaps sugar, starch in wastewater

1/10/14 | Phoenix Business Journal | Hayley Ringle

Arbsource is developing wastewater treatment systems for the food and beverage industry by using biotechnology to help cut its customers’ water and power bills.

Gilbert company grows algae with hope of profiting from its many uses

1/6/14 | Arizona Republic | Ryan Randazzo

There’s money to be made on algae, and Gilbert-based Heliae Development is on a mission to prove it.